Oppenheimer Maintains Outperform on Addus HomeCare, Raises Price Target to $140
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Michael Wiederhorn maintains an Outperform rating on Addus HomeCare (NASDAQ:ADUS) and raises the price target from $130 to $140.
August 07, 2024 | 11:56 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer analyst Michael Wiederhorn maintains an Outperform rating on Addus HomeCare and raises the price target from $130 to $140.
The raised price target and maintained Outperform rating from a reputable analyst are likely to positively influence investor sentiment and drive short-term price appreciation for ADUS.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100